Patrick Y. Wen
Impact in
- Genetics top 0.01%
- Glioma Diagnosis and Treatment
- Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism
Papers in
- Genetics 588
- Glioma Diagnosis and Treatment 585
-
- Brain Metastases and Treatment 173
- Co-authors
- Santosh Kesari (48 shared papers)David A. Reardon (139 shared papers)Timothy F. Cloughesy (152 shared papers)Eudocia Q. Lee (84 shared papers)Andrew D. Norden (72 shared papers)Jan Drappatz (88 shared papers)David Schiff (73 shared papers)Martin J. van den Bent (63 shared papers)
- Journals
- Neuro-Oncology (187 papers)Journal of Clinical Oncology (186 papers)Journal of Neuro-Oncology (51 papers)Clinical Cancer Research (23 papers)International Journal of Radiation Oncology*Biology*Physics (17 papers)
- Partner nations
- United StatesSwitzerlandNetherlands
In The Last Decade
Patrick Y. Wen
762 papers receiving 42.4k citations
Patrick Y. Wen's Hit Papers
Peers
Comparison fields: 5 of 176
- Genetics 23.9k
- Cancer Research 8.0k
- Oncology 9.9k
- Pulmonary and Respiratory Medicine 11.6k
- Neurology 5.3k
Countries citing papers authored by Patrick Y. Wen
This map shows the geographic impact of Patrick Y. Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Y. Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Y. Wen more than expected).
Fields of papers citing papers by Patrick Y. Wen
This network shows the impact of papers produced by Patrick Y. Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Y. Wen. The network helps show where Patrick Y. Wen may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Y. Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 781 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Malignant Gliomas in Adults Hit paper breakdown → | 2008 | 3341 |
| 2 | Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group Hit paper breakdown → | 2010 | 2726 |
| 3 | Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma Hit paper breakdown → | 2009 | 1855 |
| 4 | Epidemiology of Brain Metastases Hit paper breakdown → | 2011 | 942 |
| 5 | Glioma Hit paper breakdown → | 2015 | 792 |
| 6 | Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer Hit paper breakdown → | 2017 | 607 |
| 7 | Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED] Hit paper breakdown → | 2000 | 537 |
| 8 | Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study Hit paper breakdown → | 2017 | 500 |
| 9 | 2006 | 480 | |
| 10 | Immunotherapy response assessment in neuro-oncology: a report of the RANO working group Hit paper breakdown → | 2015 | 471 |
| 11 | Molecular targeted therapy of glioblastoma Hit paper breakdown → | 2019 | 466 |
| 12 | Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review Hit paper breakdown → | 2014 | 465 |
| 13 | Stereotactic Radiosurgery for the Definitive, Noninvasive Treatment of Brain Metastases Hit paper breakdown → | 1995 | 447 |
| 14 | Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study Hit paper breakdown → | 2015 | 433 |
| 15 | 2010 | 406 | |
| 16 | 2000 | 342 | |
| 17 | 2008 | 317 | |
| 18 | Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial Hit paper breakdown → | 2020 | 314 |
| 19 | 2005 | 308 | |
| 20 | 2015 | 302 |
About Patrick Y. Wen
Patrick Y. Wen is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Cancer Research, having authored 781 papers that have together received 43.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (585 papers), Brain Metastases and Treatment (173 papers), Cancer, Hypoxia, and Metabolism (98 papers), Radiomics and Machine Learning in Medical Imaging (90 papers), Cancer Genomics and Diagnostics (71 papers), Cancer Treatment and Pharmacology (63 papers), Meningioma and schwannoma management (62 papers) and Neuroblastoma Research and Treatments (61 papers). The work is most often cited by research in Genetics (23.9k citations), Cancer Research (8.0k citations), Oncology (9.9k citations), Pulmonary and Respiratory Medicine (11.6k citations) and Neurology (5.3k citations). Patrick Y. Wen has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Santosh Kesari, David A. Reardon, Timothy F. Cloughesy, Eudocia Q. Lee, Andrew D. Norden, Jan Drappatz, David Schiff, Martin J. van den Bent, Susan M. Chang and Lakshmi Nayak. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Journal of Neuro-Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.